Nebula Research & Development LLC Portfolio Holdings

Nebula Research & Development LLC

  • $836 Billion
  • Q3 2024

Nebula Research & Development LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $836 Billion distributed in 901 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Walmart Inc. with a value of $3.75B, Allstate Corp with a value of $3.76B, Stride, Inc. with a value of $3.74B, Micron Technology Inc with a value of $3.77B, and Microsoft Corp with a value of $3.77B.

Examining the 13F form we can see an increase of $219B in the current position value, from $618B to 836B.

Nebula Research & Development LLC is based out at New York, NY

Below you can find more details about Nebula Research & Development LLC portfolio as well as his latest detailed transactions.

Portfolio value $836 Billion
Technology: $131 Billion
Consumer Cyclical: $124 Billion
Industrials: $123 Billion
Healthcare: $102 Billion
Financial Services: $79.8 Billion
Consumer Defensive: $60.7 Billion
Real Estate: $51.3 Billion
Energy: $36.4 Billion
Other: $85.1 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$6.66B
$257 Million 0.03% of portfolio
4,623
Q3 2024 New
$83B
$223 Million 0.03% of portfolio
469
Q3 2024 New
$332M
$292 Million 0.03% of portfolio
63,488
Q3 2024 Reduced 50.89%
$0
$245 Million 0.03% of portfolio
30,344
Q3 2024 New
$416M
$237 Million 0.03% of portfolio
10,364
Q3 2024 Added 6.8%
$4.25B
$255 Million 0.03% of portfolio
5,309
Q3 2024 Reduced 84.73%
Soleno Therapeutics Inc
-
$220 Million 0.03% of portfolio
-
Q3 2024 New
$227M
$292 Million 0.03% of portfolio
81,735
Q3 2024 New
$11.8B
$209 Million 0.03% of portfolio
2,894
Q3 2024 New
$591M
$220 Million 0.03% of portfolio
3,413
Q3 2024 Reduced 29.93%
$1.02B
$268 Million 0.03% of portfolio
8,460
Q3 2024 Reduced 32.39%
$73.1B
$287 Million 0.03% of portfolio
2,484
Q3 2024 New
$672M
$280 Million 0.03% of portfolio
3,726
Q3 2024 New
$7.5B
$235 Million 0.03% of portfolio
1,461
Q3 2024 New
$1.57B
$177 Million 0.02% of portfolio
15,508
Q3 2024 Reduced 3.93%
$340M
$193 Million 0.02% of portfolio
12,384
Q3 2024 Reduced 35.23%
$425M
$173 Million 0.02% of portfolio
30,445
Q3 2024 Reduced 52.89%
$179M
$181 Million 0.02% of portfolio
16,787
Q3 2024 New
$263M
$168 Million 0.02% of portfolio
39,305
Q3 2024 Reduced 11.59%
Xperi Inc
-
$193 Million 0.02% of portfolio
-
Q3 2024 Reduced 14.3%
$983M
$133 Million 0.02% of portfolio
22,587
Q3 2024 Reduced 41.29%
$2.12B
$183 Million 0.02% of portfolio
28,067
Q3 2024 New
Perspective Therapeutics Inc
-
$198 Million 0.02% of portfolio
-
Q3 2024 New
$388M
$159 Million 0.02% of portfolio
11,519
Q3 2024 New
$323M
$191 Million 0.02% of portfolio
10,503
Q3 2024 Reduced 61.48%
$800M
$153 Million 0.02% of portfolio
15,280
Q3 2024 New
$32.7M
$141 Million 0.02% of portfolio
16,531
Q3 2024 New
$489M
$127 Million 0.02% of portfolio
17,044
Q3 2024 New
$2.56B
$207 Million 0.02% of portfolio
2,183
Q3 2024 New
$3.25B
$126 Million 0.02% of portfolio
19,256
Q3 2024 New
$946M
$204 Million 0.02% of portfolio
13,561
Q3 2024 New
Oaktree Specialty Lending CO
-
$176 Million 0.02% of portfolio
-
Q3 2024 New
$1.29B
$188 Million 0.02% of portfolio
13,803
Q3 2024 New
$789M
$189 Million 0.02% of portfolio
10,890
Q3 2024 Reduced 50.68%
$2.21B
$151 Million 0.02% of portfolio
32,346
Q3 2024 New
$47.4B
$206 Million 0.02% of portfolio
1,079
Q3 2024 Reduced 39.55%
$1.12B
$149 Million 0.02% of portfolio
43,167
Q3 2024 Added 20.06%
$225M
$150 Million 0.02% of portfolio
26,093
Q3 2024 Reduced 14.61%
$246M
$192 Million 0.02% of portfolio
27,682
Q3 2024 New
$471M
$181 Million 0.02% of portfolio
12,959
Q3 2024 Reduced 19.1%
$499M
$141 Million 0.02% of portfolio
45,324
Q3 2024 Added 13.57%
$1.16B
$161 Million 0.02% of portfolio
11,508
Q3 2024 New
$867M
$141 Million 0.02% of portfolio
10,107
Q3 2024 New
$6.64B
$203 Million 0.02% of portfolio
892
Q3 2024 Reduced 75.0%
$29.9B
$203 Million 0.02% of portfolio
691
Q3 2024 New
$211M
$162 Million 0.02% of portfolio
21,635
Q3 2024 Reduced 6.57%
$143M
$163 Million 0.02% of portfolio
46,631
Q3 2024 Reduced 20.1%
$179M
$181 Million 0.02% of portfolio
58,843
Q3 2024 New
$673M
$183 Million 0.02% of portfolio
46,551
Q3 2024 Reduced 29.79%

Summary

  • Portfolio
  • No. of Stocks 901
  • Current Value $836 Billion
  • Prior Value $618 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 442 stocks
  • Additional Purchases 247 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 212 stocks
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email